Translumina GmbH products

The Translumina Yukon Choice PC drug-eluting stent, coated with Rapamycin (Sirolimus) and the biodegradable component polylactide (PLA), has an excellent history of pre-clinical and long-term clinical results.

The Translumina Yukon drug-eluting stent product family, coated with Rapamycin (Sirolimus) and the biodegradable component polylactide (PLA), has an excellent history of pre-clinical and long-term clinical results.

The Translumina Yukon® CC represents a new generation of stent system technology based on a Cobalt-Chromium alloy. It is the first CoCr Stent with a unique micro-porous surface. The Yukon CC is in continuation of the Translumina Surface philosophy, improving healing and biocompatibility of the implant.